Patents Assigned to Compass Pharmaceuticals, LLC
  • Publication number: 20120178754
    Abstract: The present invention provides novel compounds and pharmaceutical compositions thereof, as well as methods for using the compounds and pharmaceutical compositions for treating tumors. Examples of specific tumor types that the compounds may be used to treat include, but are not limited to sarcomas, melanomas, neuroblastomas, carcinomas (including but not limited to lung, renal cell, ovarian, liver, bladder, and pancreatic carcinomas), and mesotheliomas.
    Type: Application
    Filed: March 22, 2012
    Publication date: July 12, 2012
    Applicant: Compass Pharmaceuticals LLC
    Inventors: Paul W. Baures, Donald R. James, Richard D. Gless, Thuy Tran, Herman J. Verheij, Jan C.C. Schultz
  • Publication number: 20120071513
    Abstract: The present invention provides novel compounds and pharmaceutical compositions thereof, as well as methods for using the compounds and pharmaceutical compositions for treating tumors. Examples of specific tumor types that the compounds may be used to treat include, but are not limited to sarcomas, melanomas, neuroblastomas, carcinomas (including but not limited to lung, renal cell, ovarian, liver, bladder, and pancreatic carcinomas), and mesotheliomas.
    Type: Application
    Filed: November 28, 2011
    Publication date: March 22, 2012
    Applicant: COMPASS PHARMACEUTICALS LLC
    Inventors: David Kanne, John Ward, Gary Look, X. Michael Wang, Diva Chan, Tina Lee, Donald R. James, Richard Gless, John Schullek, Charles Vacin
  • Publication number: 20110178087
    Abstract: The present invention provides novel compounds and pharmaceutical compositions thereof, as well as methods for using the compounds and pharmaceutical compositions for treating tumors. Examples of specific tumor types that the compounds may be used to treat include, but are not limited to sarcomas, melanomas, neuroblastomas, carcinomas (including but not limited to lung, renal cell, ovarian, liver, bladder, and pancreatic carcinomas), and mesotheliomas.
    Type: Application
    Filed: March 30, 2011
    Publication date: July 21, 2011
    Applicant: Compass Pharmaceuticals LLC.
    Inventors: David Kanne, John Ward, Gary Look, X. Michael Wang, Diva Chan, Tina Lee, Donald R. James, Richard Gless, John Schullek, Charles Vacin
  • Publication number: 20100222356
    Abstract: The present invention provides novel compounds and pharmaceutical compositions thereof, as well as methods for using the compounds and pharmaceutical compositions for treating tumors. Examples of specific tumor types that the compounds may be used to treat include, but are not limited to sarcomas, melanomas, neuroblastomas, carcinomas (including but not limited to lung, renal cell, ovarian, liver, bladder, and pancreatic carcinomas), and mesotheliomas.
    Type: Application
    Filed: May 10, 2010
    Publication date: September 2, 2010
    Applicant: Compass Pharmaceuticals LLC
    Inventors: Paul W. Baures, Donald R. James, Richard D. Gless, Thuy Tran, Herman J. Verheij, Jan C.C. Schultz
  • Publication number: 20090143411
    Abstract: The present invention provides novel compounds and pharmaceutical compositions thereof, as well as methods for using the compounds and pharmaceutical compositions for treating tumors. Examples of specific tumor types that the compounds may be used to treat include, but are not limited to sarcomas, melanomas, neuroblastomas, carcinomas (including but not limited to lung, renal cell, ovarian, liver, bladder, and pancreatic carcinomas), and mesotheliomas.
    Type: Application
    Filed: October 18, 2005
    Publication date: June 4, 2009
    Applicant: COMPASS PHARMACEUTICALS LLC
    Inventors: John Ward, Rama Jain, Donald R. James, Herman J. Verheij, Jan C.C. Schultz
  • Publication number: 20090131445
    Abstract: The present invention provides novel compounds of the formula (I) and pharmaceutical compositions thereof, as well as methods for using the compounds and pharmaceutical compositions for treating tumors. Examples of specific tumor types that the compounds may be used to treat include, but are not limited to sarcomas, melanomas, neuroblastomas, carcinomas (including but not limited to lung, renal cell, ovarian, liver, bladder, and pancreatic carcinomas), and mesotheliomas.
    Type: Application
    Filed: October 12, 2005
    Publication date: May 21, 2009
    Applicant: COMPASS PHARMACEUTICALS LLC
    Inventors: Paul W. Baures, Donald R. James, Richard D. Gless, Thuy Tran, Jan C.C. Schultz
  • Publication number: 20090018145
    Abstract: The present invention provides novel compounds and pharmaceutical compositions thereof, as well as methods for using the compounds and pharmaceutical compositions for treating tumors. Examples of specific tumor types that the compounds may be used to treat include, but are not limited to sarcomas, melanomas, neuroblastomas, carcinomas (including but not limited to lung, renal cell, ovarian, liver, bladder, and pancreating carcinomas) and mesotheliomas.
    Type: Application
    Filed: October 18, 2005
    Publication date: January 15, 2009
    Applicant: Compass Pharmaceuticals LLC
    Inventors: David Kanne, John Ward, Gary Look, X. Michael Wang, Diva Chan, Tina Lee, Donald R. James, Richard Gless, John Schullek, Charles Vacin
  • Publication number: 20040167180
    Abstract: Disclosed and claimed is a method for treating tumors using sulfonylamino-substituted N-aryl- or heteroarylcarboxamide derivatives.
    Type: Application
    Filed: February 23, 2004
    Publication date: August 26, 2004
    Applicant: Compass Pharmaceuticals, LLC
    Inventor: Irwin Braude
  • Patent number: 6716879
    Abstract: Disclosed and claimed is a method for treating tumors using sulfonylamino-substituted N-aryl- or heteroarylcarboxamide derivatives.
    Type: Grant
    Filed: August 29, 2001
    Date of Patent: April 6, 2004
    Assignee: Compass Pharmaceuticals, LLC
    Inventor: Irwin Braude